 |
 |

Antibiotic Use for Upper Respiratory Tract Infections
How Well Do Pediatric Residents Do?
Sumathi Nambiar, MD;
Richard H. Schwartz, MD;
Michael J. Sheridan, ScD
Arch Pediatr Adolesc Med. 2002;156:621-624.
Background Antibiotics are often used inappropriately for the treatment of upper
respiratory tract infections in children, and the emergence of resistant bacteria
is a growing public health concern.
Objective To assess awareness and compliance with the Centers for Disease Control
and Prevention (Atlanta, Ga) and American Academy of Pediatrics (Elk Grove
Village, Ill) principles for judicious antibiotic use for upper respiratory
tract infections among residents from a sample of pediatric residency programs
in the mid-Atlantic region of the United States.
Participants and Methods Residents at the participating programs were requested to complete a
survey questionnaire.
Results Of the 524 pediatric residents surveyed, 74% (388 participants) completed
the questionnaire. Familiarity with the principles increased with a year of
training; 16%, 36%, and 50% of first-year (PL1), second-year (PL2), and third-
or fourth-year (PL3/PL4) residents, respectively, had heard or read about
the principles ( 2trend; P<.001).
In response to a direct question about the use of antibiotics for an otherwise
well, afebrile 18-month-old child with purulent rhinorrhea, 29%, 25%, and
15% of PL1, PL2, and PL3/PL4 residents, respectively, would prescribe antibiotics
within 10 days of onset of illness ( 2trend; P = .008). A significant difference was found between PL1
vs PL3/PL4 participants (difference = 20%; 95% CI = 3%-26%). If the same infant
had a temperature of 38.8°C, then 63%, 45%, and 47% of PL1, PL2, and PL3/PL4
residents, respectively, would prescribe antibiotics ( 2trend; P = .008).
Conclusions Awareness among pediatric residents about the judicious use of antibiotics
for upper respiratory tract infections is often lacking, and inappropriate
use of antibiotics for this condition continues to be prevalent. This was
especially noted among PL1 residents, with an improving trend noted with increasing
years of training.
From the Department of Pediatrics, Inova Fairfax Hospital for Children
(Drs Nambiar and Schwartz), and the Department of Medicine, Inova Fairfax
Hospital (Dr Sheridan), Falls Church, Va. Dr Nambiar is now with the Food
and Drug Administration and the Children's National Medical Center, Washington,
DC.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Provider and Practice Characteristics Associated With Antibiotic Use in Children With Presumed Viral Respiratory Tract Infections
Gaur et al.
Pediatrics 2005;115:635-641.
ABSTRACT
| FULL TEXT
|